This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Parkinson's disease, strict definition
PDSTRICT
secondary Parkinson disease: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
5502 |
4. Check minimum number of eventsNone |
5502 |
5. Include endpointsNone |
5502 |
6. Filter based on genotype QC (FinnGen only) |
5502 |
Control definitions (FinnGen only)
- Control exclude
- G6_PARKINSON
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G20-G26
- Name in latin
- Morbus Parkinson
Similar endpoints
↥List of similar endpoints to
Parkinson's disease, strict definition
based on the number of shared cases.
Similar with more cases:
- Parkinson's disease, strict definition, excluding more controls
- Parkinson's disease, excluding more controls
- Parkinson's disease
- Parkinson's disease, including avohilmo
- Extrapyramidal and movement disorders
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5502 | 2157 | 3345 |
| Unadjusted period prevalence (%) | 1.18 | 0.74 | 1.47 |
| Median age at first event (years) | 70.35 | 69.52 | 70.89 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4838
- Matched controls
- 48387
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N04BC09
ATC
rotigotine; transdermal
226.5
323.0
357
17
N04BC05
ATC
pramipexole; oral
15.1
323.0
1807
1834
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
52.0
323.0
546
118
N04BX02
ATC
entacapone; oral
2127.0
323.0
412
*
N04BC04
ATC
ropinirole; oral
234.3
323.0
1048
57
N87
ICPC
Parkinsonism
274.7
323.0
1392
71
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
15290.8
323.0
1176
*
G20
ICD-10 Finland
Parkinson disease
12413.4
323.0
4644
46
193
Kela drug reimbursment
Rasagiline
+∞
323.0
708
*
N04BD02
ATC
rasagiline; oral
5180.1
323.0
878
*
R25.1
ICD-10 Finland
Tremor, unspecified
21.9
323.0
888
491
N06DA03
ATC
rivastigmine; oral, transdermal
8.5
323.0
800
1105
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
323.0
563
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
323.0
3975
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
632.6
323.0
3925
328
N04BD01
ATC
selegiline; oral
810.1
323.0
1771
34
N05AH04
ATC
quetiapine; oral
4.2
260.8
1162
3391
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
682.4
200.7
197
*
N04BB01
ATC
amantadine; oral
16.0
196.0
328
219
N03AE01
ATC
clonazepam; systemic
5.4
185.7
611
1269
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
81.3
172.8
195
25
N04AA02
ATC
biperiden; systemic
13.6
170.0
304
237
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.2
150.6
640
1712
C07AA05
ATC
propranolol; systemic
2.9
148.5
1072
4311
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
175.4
146.4
153
9
G04BD12
ATC
mirabegron; oral
3.1
142.2
902
3317
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
1422.9
141.3
137
*
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
60.3
129.2
152
26
H02AA02
ATC
fludrocortisone; oral
14.9
120.3
206
144
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
+∞
118.2
113
*
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
90.2
110.6
123
14
G25.0
ICD-10 Finland
Essential tremor
6.1
107.6
311
541
R53
ICD-10 Finland
Malaise and fatigue
2.2
104.5
1272
6633
I95.1
ICD-10 Finland
Orthostatic hypotension
4.1
98.6
419
1103
AA1AD
NOMESCO Finland
CT of head and brain
2.0
96.1
1550
9067
N04BC02
ATC
pergolide; oral
166.6
93.5
98
6
A28
ICPC
Limited function/disability NOS
2.2
92.6
1164
6105
SPAT1229
SPAT
Assessment of need for aid
2.8
90.6
666
2630
XF606
NOMESCO Finland
Ortostatic test
13.4
90.2
161
124
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
88.1
545
1921
XA800
NOMESCO Finland
Neuropsychological investigation
5.1
86.8
290
598
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
85.4
1610
9902
A06AD11
ATC
lactulose; oral
2.2
85.4
1096
5770
N04BC06
ATC
cabergoline; oral (dopamine agonists)
28.6
81.8
112
40
L28
ICPC
Limited function/disability (L)
2.1
80.8
1086
5813
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
78.8
1721
11076
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
76.8
1072
5815
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.1
76.1
466
1626
N06AX11
ATC
mirtazapine; oral
1.9
75.8
1531
9555
SPAT1216
SPAT
Assessment of functional ability
2.1
73.1
1053
5768
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
30.0
71.8
97
33
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
7.7
70.1
168
224
G25.2
ICD-10 Finland
Other specified forms of tremor
16.6
68.9
112
69
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
67.7
434
1558
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
75.2
65.2
74
10
G02CB01
ATC
bromocriptine; systemic
12.0
63.9
119
101
R1250
NOMESCO Finland
Evaluation of functional capability
6.0
62.9
181
312
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.7
61.8
449
1742
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
61.4
845
4504
R4130
NOMESCO Finland
Speech therapy
4.9
60.6
207
436
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.4
59.6
306
935
N29
ICPC
Neurological sympt/complt other
5.4
58.7
184
352
N19
ICPC
Speech disorder
7.0
57.1
146
215
G21.8
ICD-10 Finland
Other secondary parkinsonism
53.0
56.9
68
13
N06AB10
ATC
escitalopram; oral
2.1
56.3
751
3937
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
554.2
55.7
55
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
54.0
1050
6332
N28
ICPC
Limited function/disability (N)
5.5
52.3
161
302
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
12.4
51.9
95
78
N05BA04
ATC
oxazepam; oral
1.8
51.7
1184
7516
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.4
51.0
476
2111
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
50.3
914
5364
D21
ICPC
Swallowing problem
5.5
49.4
151
281
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.0
48.8
207
540
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
48.0
809
4619
SPAT1234
SPAT
Support of social functional capacity
2.6
47.8
372
1496
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.3
46.4
454
2058
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
11.5
46.0
87
77
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.4
45.7
432
1925
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
44.3
358
1468
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
44.1
545
2745
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.4
42.5
221
681
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.5
40.3
332
1373
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.8
40.1
178
483
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
+∞
39.6
38
*
G90.3
ICD-10 Finland
Multi-system degeneration
58.0
39.3
46
8
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
38.0
279
1083
U04
ICPC
Incontinence urine
2.5
37.7
306
1255
N03AX12
ATC
gabapentin; oral
1.8
37.7
740
4418
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.7
37.6
173
484
A04
ICPC
Weakness/tiredness general
1.9
37.6
666
3838
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
37.6
1410
10083
R47.1
ICD-10 Finland
Dysarthria and anarthria
5.9
36.6
104
178
S01.0
ICD-10 Finland
Open wound of scalp
2.1
36.2
441
2203
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.6
34.7
163
465
R35
ICD-10 Finland
Polyuria
2.1
34.5
398
1940
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
10.8
34.0
66
62
N06AB04
ATC
citalopram; systemic
1.6
33.9
931
6119
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
33.8
372
1774
M48.0
ICD-10 Finland
Spinal stenosis
1.7
32.9
704
4305
N05AH03
ATC
olanzapine; systemic
2.8
32.3
224
837
N30.0
ICD-10 Finland
Acute cystitis
1.8
32.0
655
3947
AA5QN
NOMESCO Finland
NA
88.2
31.7
35
*
S72.0
ICD-10 Finland
Fracture of neck of femur
2.3
30.9
296
1323
P20
ICPC
Memory disturbance
1.7
30.6
771
4936
N08
ICPC
Abnormal involuntary movements
17.3
30.5
48
28
M54.5
ICD-10 Finland
Low back pain
1.5
30.4
1264
9163
N04BX04
ATC
opicapone; oral
+∞
30.2
29
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.3
30.2
303
1382
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.5
30.1
147
433
130
Kela drug reimbursment
Malignant tumour
0.4
30.1
114
2889
R13
ICD-10 Finland
Dysphagia
2.1
30.0
367
1831
R60.0
ICD-10 Finland
Localized oedema
1.8
29.5
593
3548
N04AA01
ATC
trihexyphenidyl; oral
50.3
29.3
35
7
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
50.3
29.3
35
7
34200
ICD-8 Finland
Paralysis agitans, Parkinsonismus
+∞
29.2
28
*
N04BC07
ATC
apomorphine; parenteral
+∞
29.2
28
*
G04BD08
ATC
solifenacin; oral
2.0
29.1
399
2088
N99
ICPC
Neurological disease other
4.7
28.8
99
212
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.2
28.2
304
1434
F0232, G20
ICD-10 Finland
NA
+∞
27.1
26
*
F0230, G20
ICD-10 Finland
NA
+∞
27.1
26
*
SPAT1053
SPAT
Memory test
1.5
26.4
942
6564
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
3.7
26.4
119
330
K59.0
ICD-10 Finland
Constipation
2.1
26.3
323
1616
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
29.4
26.3
35
12
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
13.3
25.9
45
34
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.6
25.8
201
808
R2110
NOMESCO Finland
Giving the first information
2.2
25.6
272
1277
N05AX08
ATC
risperidone; systemic
1.9
25.5
398
2181
N03AG01
ATC
valproic acid; systemic, rectal
2.3
25.4
245
1098
N04BC01
ATC
bromocriptine; oral
39.0
24.8
31
8
N05AH02
ATC
clozapine; systemic
6.0
24.6
68
114
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
24.5
388
2136
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
24.3
699
4613
W19
ICD-10 Finland
Unspecified fall
1.8
24.1
462
2713
L03
ICPC
Low back symptom/complaint
1.5
24.0
936
6635
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
2.5
23.5
183
735
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.7
23.0
102
280
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.9
22.6
95
249
R1260
NOMESCO Finland
Evaluation of communicative skills
3.2
22.0
118
375
N04BX01
ATC
tolcapone; oral
+∞
21.9
21
*
R41.0
ICD-10 Finland
Disorientation, unspecified
2.3
21.9
205
907
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
4.9
21.5
71
147
Z75.5
ICD-10 Finland
Holiday relief care
3.8
21.3
92
247
N02BE01
ATC
paracetamol; systemic, rectal
1.4
21.3
3850
35464
N06AX16
ATC
venlafaxine; oral
1.8
21.2
398
2318
R55
ICD-10 Finland
Syncope and collapse
1.6
21.0
580
3776
R23
ICPC
Voice symptom/complaint
3.5
20.7
98
284
S06.0
ICD-10 Finland
Concussion
1.7
20.7
426
2553
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
20.7
1096
8239
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
110.5
20.6
22
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
20.4
350
1977
J01EA01
ATC
trimethoprim; systemic
1.4
20.1
1080
8133
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
4.7
20.0
69
150
SPAT1254
SPAT
Administration of medicine
1.5
19.9
715
4956
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.6
19.8
89
248
XKD00
NOMESCO Finland
Uroflowmetry
1.4
19.7
949
6995
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
19.5
383
2264
SPAT1301
SPAT
No procedures
1.4
19.3
1441
11476
R42
ICD-10 Finland
Dizziness and giddiness
1.4
19.1
1038
7821
N86
ICPC
Multiple sclerosis
7.4
19.1
45
61
H02AB02
ATC
dexamethasone; systemic
0.5
19.0
140
2803
R32
ICD-10 Finland
Unspecified urinary incontinence
2.5
18.7
153
634
TAB00
NOMESCO Finland
Lumbar puncture
2.4
18.6
161
685
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.3
18.4
92
280
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.7
18.3
428
2662
N06AX21
ATC
duloxetine; oral
1.7
18.2
368
2194
F06.0
ICD-10 Finland
Organic hallucinosis
11.4
17.9
33
29
R44.1
ICD-10 Finland
Visual hallucinations
6.0
17.9
49
82
G04BD09
ATC
trospium; oral
2.5
17.9
147
608
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.6
17.8
257
4261
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
17.7
261
1398
S70.0
ICD-10 Finland
Contusion of hip
2.1
17.7
197
945
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
17.7
17
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.6
17.6
445
2825
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.4
17.6
145
603
G04BD11
ATC
fesoterodine; oral
2.2
17.5
178
819
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.2
17.2
177
821
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
17.1
319
1853
G04CA02
ATC
tamsulosin; oral
1.3
17.0
1395
11233
K02.1
ICD-10 Finland
Caries of dentine
1.3
16.8
1862
15653
A03FA01
ATC
metoclopramide; systemic, rectal
0.7
16.8
435
6339
R60.9
ICD-10 Finland
Oedema, unspecified
2.0
16.7
227
1182
H50.52
ICD-10 Finland
Exophoria
5.0
16.6
53
107
J01CA08
ATC
pivmecillinam; oral
1.3
16.6
1323
10594
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
16.6
742
5374
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
170.5
16.5
17
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
16.0
709
5120
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
6.4
15.9
41
64
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.2
15.8
82
257
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
15.8
1765
14824
F02.3
ICD-10 Finland
Dementia in Parkinson disease
160.5
15.5
16
*
N06AX03
ATC
mianserin; oral
1.9
15.3
222
1183
G04BD04
ATC
oxybutynin; oral, transdermal
1.7
15.3
296
1741
Z29
ICPC
Social problem NOS
2.9
15.3
91
315
G04BD07
ATC
tolterodine; oral
1.8
15.0
270
1552
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
14.8
1302
10545
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.1
14.8
169
824
P29
ICPC
Psychological sympt/compl other
2.3
14.7
135
595
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
14.6
413
2698
G23.2
ICD-10 Finland
Multiple system atrophy, parkinsonian type [MSA-P]
80.3
14.6
16
*
N87
ICD-10 Finland
Dysplasia of cervix uteri
80.3
14.6
16
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
14.5
181
914
M03BX01
ATC
baclofen; systemic
3.1
14.5
78
252
SPAT1050
SPAT
Extensive neurological examination
2.5
14.3
113
462
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.0
14.3
57
145
C01CA01
ATC
etilefrine; systemic
3.6
14.2
63
176
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
14.2
553
3888
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.3
14.1
69
208
AA1AA
NOMESCO Finland
Head X-ray examination
3.8
14.1
59
157
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
13.7
248
1428
I95.9
ICD-10 Finland
Hypotension, unspecified
2.7
13.6
94
358
F023, G20
ICD-10 Finland
NA
+∞
13.5
13
*
F0234, G20
ICD-10 Finland
NA
+∞
13.5
13
*
RF120
NOMESCO Finland
NA
3.4
13.5
65
194
E86
ICD-10 Finland
Volume depletion
2.2
13.3
139
652
H50.31
ICD-10 Finland
Intermittent exotropia
5.4
13.2
39
73
Z50.1
ICD-10 Finland
Other physical therapy
1.8
13.1
241
1398
R5110
SPAT
NA
2.2
13.1
133
618
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.3
12.8
33
987
SPAT1167
SPAT
Insertion of urinary catheter
1.9
12.8
201
1106
Z50.5
ICD-10 Finland
Speech therapy
3.3
12.8
62
187
K11.72
ICD-10 Finland
Xerostomia
14.1
12.7
21
15
M04AA01
ATC
allopurinol; systemic
0.7
12.7
383
5444
L17
ICPC
Foot/toe symptom/complaint
1.3
12.6
993
7883
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.3
12.6
27
881
R44.3
ICD-10 Finland
Hallucinations, unspecified
5.7
12.5
35
62
C03CA01
ATC
furosemide; systemic
1.3
12.5
1690
14425
M41.9
ICD-10 Finland
Scoliosis, unspecified
3.2
12.3
64
203
G35
ICD-10 Finland
Multiple sclerosis
3.8
12.3
50
131
K08.3
ICD-10 Finland
Retained dental root
1.7
12.1
281
1742
F05.9
ICD-10 Finland
Delirium, unspecified
2.2
12.1
118
538
SPAT1240
SPAT
Therapeutic discussion
1.7
12.1
247
1477
S00.0
ICD-10 Finland
Superficial injury of scalp
2.4
12.0
101
430
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.1
12.0
127
601
N05BA01
ATC
diazepam; systemic, rectal
1.4
12.0
542
3919
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
11.9
823
6402
M41.4
ICD-10 Finland
Neuromuscular scoliosis
46.8
11.9
14
*
R4110
SPAT
NA
2.2
11.8
121
562
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
8.4
11.8
25
30
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.3
11.7
26
829
S01.9
ICD-10 Finland
Open wound of head, part unspecified
2.7
11.7
79
299
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
11.6
373
2510
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
11.6
156
814
G24.9
ICD-10 Finland
Dystonia, unspecified
7.7
11.6
26
34
RF420
NOMESCO Finland
NA
3.0
11.6
64
213
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.3
11.6
104
457
AAG99
NOMESCO Finland
Other stereotactic intracranial operation
+∞
11.5
11
*
359
Kela drug reimbursment
Mirabegroni
3.9
11.4
45
115
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.3
11.4
103
454
UKC02
NOMESCO Finland
Cystoscopy
1.3
11.4
862
6796
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.2
11.3
58
184
L84
ICD-10 Finland
Corns and callosities
2.0
11.1
147
762
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
3.7
11.0
46
124
D12
ICPC
Constipation
1.9
11.0
159
854
WYA20
NOMESCO Finland
Home visit
2.4
10.9
90
377
N03AX09
ATC
lamotrigine; oral
2.2
10.9
107
489
H02AB06
ATC
prednisolone; systemic
0.8
10.9
1489
17228
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.7
10.9
232
1406
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
4.9
10.8
34
70
WX290
NOMESCO Finland
Other blockade of nerve
1.3
10.8
1175
9729
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
2.3
10.6
100
449
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
10.5
1746
15177
S01.8
ICD-10 Finland
Open wound of other parts of head
2.8
10.5
66
239
SPAT1172
SPAT
Guidance concerning hydration
2.0
10.5
132
673
Z02.4
ICD-10 Finland
Examination for driving licence
0.8
10.4
819
10100
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.2
10.4
106
494
S22.3
ICD-10 Finland
Fracture of rib
1.6
10.4
279
1801
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.7
10.4
234
1441
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.5
10.4
77
307
A29
ICPC
General symptom/complaint other
1.4
10.3
467
3375
R63.4
ICD-10 Finland
Abnormal weight loss
1.9
10.3
155
843
N05AX12
ATC
aripiprazole; systemic
2.8
10.2
65
237
R30.1
ICD-10 Finland
Vesical tenesmus
2.4
10.2
83
347
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.1
10.2
6
415
G72.8
ICD-10 Finland
Other specified myopathies
2.4
10.2
80
330
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
5.0
10.1
31
62
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
10.1
161
894
N05AN01
ATC
lithium; oral
2.6
10.1
72
282
A06AX04
ATC
linaclotide; oral
8.4
10.0
21
25
G21.2
ICD-10 Finland
Secondary parkinsonism due to other external agents
40.1
10.0
12
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.8
9.9
62
222
W06
ICD-10 Finland
Fall involving bed
3.2
9.9
49
152
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.4
9.8
37
936
P03
ICPC
Feeling depressed
1.8
9.8
177
1024
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
10.6
9.8
18
17
Z02.7
ICD-10 Finland
Issue of medical certificate
1.6
9.8
236
1485
SPAT1262
SPAT
Handing over of treatment supplies
1.3
9.7
812
6477
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.6
9.7
70
276
EBA00
NOMESCO Finland
Extraction of tooth
1.3
9.7
1122
9338
N06DA02
ATC
donepezil; oral
1.5
9.7
306
2055
R33
ICD-10 Finland
Retention of urine
1.4
9.6
436
3153
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.6
9.6
66
254
S20.2
ICD-10 Finland
Contusion of thorax
1.7
9.6
184
1086
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
9.5
622
4783
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
9.5
628
4840
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
3.5
9.5
43
125
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.9
9.5
37
95
N05AB03
ATC
perphenazine; systemic, rectal
2.0
9.5
122
628
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
9.5
854
6882
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.2
9.4
87
391
G23.3
ICD-10 Finland
Multiple system atrophy, cerebellar type [MSA-C]
+∞
9.4
9
*
Z60.8
ICD-10 Finland
Other problems related to social environment
5.8
9.3
25
43
XKC03
NOMESCO Finland
Water cystometry
1.9
9.3
133
712
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
3.8
9.3
37
97
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
8.7
9.3
19
22
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
9.3
253
1643
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
0.4
9.2
31
821
RF410
NOMESCO Finland
NA
2.9
9.2
53
182
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
3.0
9.2
50
167
Z11
ICPC
Compliance/being ill problem
3.7
9.2
38
103
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
9.1
2044
18240
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.4
9.0
435
3178
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
3.9
9.0
35
90
Y94.0
ICD-10 Finland
Accident at home
2.2
9.0
91
425
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.3
9.0
658
5152
N06AX26
ATC
vortioxetine; oral
1.9
9.0
131
709
SPAT1244
SPAT
Occupational therapy
2.7
9.0
57
209
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
4.8
9.0
28
58
N05CD07
ATC
temazepam; oral
1.3
8.9
611
4732
H53.2
ICD-10 Finland
Diplopia
1.9
8.9
126
672
L01BC06
ATC
capecitabine; oral
0.4
8.9
34
852
L29
ICPC
Musculoskeletal sympt/complt other
1.5
8.8
278
1865
K07
ICPC
Swollen ankles/oedema
1.6
8.8
207
1294
M79.6
ICD-10 Finland
Pain in limb
1.2
8.7
1307
11184
SPAT1101
SPAT
Orthostatic test
1.6
8.7
231
1491
K88
ICPC
Postural hypotension
2.9
8.7
51
179
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
8.7
147
836
N03AA03
ATC
primidone; oral
5.8
8.6
23
40
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
3.0
8.6
49
167
P01
ICPC
Feeling anxious/nervous/tense
1.7
8.5
162
955
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
4.4
8.5
29
66
G22
ICD-10 Finland
Parkinsonism in diseases classified elsewhere
90.2
8.4
9
*
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.9
8.4
120
645
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.3
8.4
74
326
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.3
8.4
624
4894
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.6
8.4
57
217
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
4.2
8.4
30
72
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.3
8.3
557
4299
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.8
8.3
131
729
RF433
NOMESCO Finland
NA
10.7
8.3
15
14
R03BB04
ATC
tiotropium bromide; inhalant
0.7
8.2
264
3718
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
0.1
8.2
*
264
K03.66
ICD-10 Finland
Tooth plaque
1.6
8.2
207
1321
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.4
8.2
396
2898
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.8
8.2
49
175
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
8.2
638
5035
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
8.2
164
984
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
0.7
8.2
252
3573
183
Kela drug reimbursment
Lamotrigin and topiramate
4.1
8.1
30
74
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
8.1
431
3203
U07
ICPC
Urine symptom/complaint other
1.5
8.1
234
1541
H02.3
ICD-10 Finland
Blepharochalasis
1.5
8.1
249
1664
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
8.1
454
3408
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.4
8.1
388
2836
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.5
8.1
259
1745
N03AF02
ATC
oxcarbazepine; oral
1.9
8.1
109
574
EBA30
NOMESCO Finland
Excision of root of tooth
1.6
8.1
207
1325
G04CB02
ATC
dutasteride; oral
1.4
8.0
360
2600
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
2.3
8.0
71
312
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.7
8.0
159
951
WF002
NOMESCO Finland
Radical radiotherapy
0.6
8.0
86
1536
R26
ICD-10 Finland
Abnormalities of gait and mobility
5.2
8.0
23
44
N03AX16
ATC
pregabalin; oral
1.3
7.9
877
7238
M40.1
ICD-10 Finland
Other secondary kyphosis
7.2
7.9
18
25
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.9
7.9
106
559
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.6
7.9
194
1230
L02
ICPC
Back symptom/complaint
1.5
7.9
258
1750
SPAT1263
SPAT
Sampling
1.2
7.8
1680
14864
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.4
7.8
61
251
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.1
7.8
86
420
SPAT1360
SPAT
Extensive global examination
1.4
7.8
317
2247
JN4BD
NOMESCO Finland
Extensive body CT
0.7
7.8
273
3782
F22.0
ICD-10 Finland
Delusional disorder
2.4
7.7
60
247
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.5
7.6
281
1952
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.7
7.6
145
857
AXX01
NOMESCO Finland
Memory assessment
18.4
7.6
11
6
N04AB02
ATC
orphenadrine (chloride); systemic
25.0
7.6
10
*
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
7.6
1141
9748
G25
ICD-10 Finland
Other extrapyramidal and movement disorders
8.8
7.5
15
17
G25.1
ICD-10 Finland
Drug-induced tremor
6.1
7.5
19
31
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.9
7.5
99
519
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.6
7.5
53
209
S01
ICD-10 Finland
Open wound of head
2.5
7.5
54
216
R25.8
ICD-10 Finland
Other and unspecified abnormal involuntary movements
5.7
7.5
20
35
N17
ICPC
Vertigo/dizziness
1.3
7.5
454
3451
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
7.5
147
876
B03BA03
ATC
hydroxocobalamin; parenteral
1.4
7.4
290
2039
WX110
NOMESCO Finland
Local anesthesy
1.2
7.4
2438
22363
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.0
7.3
40
136
N04C02
ATC
NA
+∞
7.3
7
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
2.5
7.3
52
207
R39.1
ICD-10 Finland
Other difficulties with micturition
1.7
7.3
133
777
RF210
NOMESCO Finland
NA
1.9
7.3
99
525
SPAT1304
SPAT
Counselling and guidance related to ageing
1.4
7.3
363
2672
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.3
7.3
512
3981
N06AB06
ATC
sertraline; oral
1.5
7.2
275
1926
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
7.2
406
3048
J01MA02
ATC
ciprofloxacin; systemic
1.2
7.2
1682
14968
A08
ICPC
Swelling
1.6
7.2
176
1116
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.7
7.2
132
772
N02CA01
ATC
dihydroergotamine; nasal, systemic
4.1
7.2
26
64
N02AA05
ATC
oxycodone; systemic
1.3
7.1
675
5460
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.4
7.1
35
796
AA400
NOMESCO Finland
Electroconvulsive therapy
3.6
7.1
30
84
AA052
NOMESCO Finland
NA
20.0
7.1
10
5
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.0
7.1
37
122
A03FA02
ATC
cisapride; oral, rectal
1.4
7.1
336
2451
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
12.0
7.1
12
10
Z43.1
ICD-10 Finland
Attention to gastrostomy
8.8
7.0
14
16
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
7.0
522
4091
C10AA07
ATC
rosuvastatin; oral
0.8
7.0
696
8396
L76
ICPC
Fracture: other
1.8
7.0
114
643
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.6
7.0
94
1585
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
1.9
7.0
92
480
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
2.2
7.0
65
296
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
7.0
291
2076
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
2.7
6.9
43
159
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.8
6.9
117
669
SPAT1104
SPAT
Monitoring of emergency patient
1.4
6.9
265
1861
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.4
6.9
364
2708
C10AX09
ATC
ezetimibe; oral
0.7
6.8
250
3442
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
6.8
375
2808
M43.1
ICD-10 Finland
Spondylolisthesis
1.7
6.8
129
764
SPAT1260
SPAT
Consultation of another employee
1.3
6.8
689
5628
3321A
ICD-9 Finland
Parkinson's disease, Secondary Parkinsonism
40.1
6.8
8
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
3.1
6.7
34
110
A01
ICPC
Pain general/multiple sites
1.4
6.7
278
1978
N05AA02
ATC
levomepromazine; systemic
1.7
6.7
140
852
N05AF03
ATC
chlorprothixene; systemic
2.0
6.7
77
383
K56.2
ICD-10 Finland
Volvulus
2.8
6.7
39
138
U02
ICPC
Urinary frequency/urgency
1.3
6.7
452
3498
K90
ICPC
Stroke/cerebrovascular accident
1.7
6.6
137
829
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.5
6.6
247
1724
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.3
6.6
721
5936
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.7
6.6
149
2233
G24.3
ICD-10 Finland
Spasmodic torticollis
3.2
6.6
31
96
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
0.6
6.6
71
1260
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.2
6.6
7
329
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.9
6.5
90
480
A04AA02
ATC
granisetron; systemic, transdermal
0.6
6.5
84
1424
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.9
6.5
92
495
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
6.2
6.5
16
26
SPAT1139
SPAT
Nutrition survey
1.7
6.4
130
783
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.7
6.4
125
746
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.1
6.4
66
315
3010
Kela drug reimbursment
Midodrine
69.9
6.4
7
*
G21
ICD-10 Finland
Secondary parkinsonism
69.9
6.4
7
*
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.4
1328
11665
RF214
NOMESCO Finland
NA
7.4
6.4
14
19
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.6
6.4
42
161
S01.3
ICD-10 Finland
Open wound of ear
2.4
6.3
47
193
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
4.9
6.3
19
39
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
6.5
6.3
15
23
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
6.3
1762
15876
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
6.3
317
2339
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
9.2
6.3
12
13
TKC22
NOMESCO Finland
Catheterisation instruction
1.8
6.3
104
592
F02.33
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly depression
+∞
6.2
6
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
6.2
856
7228
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.3
6.2
54
240
U05
ICPC
Urination problems other
1.5
6.2
201
1365
R43.0
ICD-10 Finland
Anosmia
3.2
6.2
29
90
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
0.7
6.2
146
2170
N05BA12
ATC
alprazolam; oral
1.4
6.1
337
2522
R4110
NOMESCO Finland
Physiotherapy
1.2
6.1
1024
8811
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.4
6.1
326
2431
3AX01
NOMESCO Finland
NA
4.6
6.1
19
41
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.3
6.1
423
3283
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
1.8
6.1
100
566
TJD20
NOMESCO Finland
Change of gastrostomy tube
3.7
6.1
24
65
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.0
6.1
32
108
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.5
6.0
220
1531
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
6.0
1200
10494
CBB11
NOMESCO Finland
Resection of lax skin in upper eyelid
1.8
6.0
90
494
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
94
108
8.84
75.04
1.8
1.2
114.7
136.6
nmol/l
0.44
53
81
2091
15105
1.62
60.65
2.5
2.2
240.5
218.3
u/l
0.45
1962
14034
1568
11025
1.59
48.34
1.9
1.8
1173.3
1166.5
nmol/l
0.11
1198
8146
2651
20968
1.51
47.48
2.3
2.1
87.7
92.7
pmol/l
7.69
1598
10916
3588
30423
1.52
44.57
6.6
5.1
2098.5
2221.7
e6/l
0.03
73
519
2976
24782
1.44
36.94
5.4
6.9
1.2
1.2
mmol/l
1.02
2529
20737
1667
12536
1.47
35.25
1.7
1.6
18.4
20.1
nmol/l
5.10
1458
10568
1442
10924
1.43
28.03
1.8
1.7
408.8
28457936.0
pmol/l
6.97
1180
8778
1205
8837
1.47
27.82
1.9
1.9
—
—
—
0
0
2679
22543
1.37
27.70
5.0
6.1
1.2
1.2
mmol/l
0.16
2394
20196
2558
21410
1.36
27.15
5.1
4.0
0.0
0.0
estimate
0.00
453
3956
878
6116
1.52
25.94
1.9
1.8
—
—
—
0
0
870
6083
1.51
25.19
1.9
1.8
—
—
—
0
0
2568
21718
1.34
24.49
5.2
4.1
0.0
0.0
estimate
1.08
460
3863
2534
21434
1.34
23.93
6.9
5.4
0.0
0.0
estimate
0.00
465
3980
200
923
2.21
23.73
1.4
1.2
472.7
599.7
mg/l
3.15
188
862
177
784
2.30
23.18
1.4
1.3
4.4
28.9
e6/l
2.06
146
611
176
784
2.29
22.75
1.5
1.4
297.4
1130.6
e6/l
2.29
156
644
2067
17061
1.34
22.65
4.4
4.0
151.6
114.9
e6/l
0.75
1565
12624
2317
19468
1.33
22.38
4.7
4.2
64.9
90.8
ng/l
0.40
1856
15254
1726
13887
1.35
22.35
3.7
3.4
0.4
0.5
e6/l
1.64
1364
10662
492
3107
1.64
22.05
1.5
1.5
—
—
—
0
0
1985
16360
1.33
21.71
5.7
4.4
—
—
—
0
0
1860
15185
1.34
21.70
3.9
3.5
94.2
108.8
e6/l
0.15
1479
11896
1257
9691
1.39
21.08
5.6
4.5
1.0
1.0
kg/l
0.97
205
1558
3429
30670
1.31
20.13
3.9
3.8
15.4
15.1
pmol/l
10.58
3048
27073
3152
28004
1.29
18.76
5.0
4.9
6.7
6.9
mmol/l
8.01
2995
26374
170
810
2.13
18.68
1.3
1.2
3.9
3.9
mmol/l
0.28
158
748
91
340
2.70
17.21
1.1
1.0
252.0
330.0
ng/l
2.41
62
219
91
341
2.70
17.11
1.1
1.0
33.6
45.9
ng/l
2.90
60
217
91
342
2.69
17.02
1.1
1.0
621.9
682.7
ng/l
0.72
60
213
1103
8582
1.36
16.96
3.2
3.0
1.3
1.2
e6/l
0.30
672
5104
2468
21438
1.27
16.76
3.8
4.8
34.6
34.5
g/l
0.63
2255
19707
494
3362
1.52
15.89
2.0
1.7
—
—
—
0
0
71
244
2.93
15.71
1.1
1.1
1.5
8.4
nmol/l
—
9
60
1587
13123
1.29
15.67
2.3
2.3
3.0
3.1
mg/l
1.33
1308
11081
1339
10831
1.31
15.58
2.9
2.7
4.9
4.4
e6/l
1.02
1180
9472
75
277
2.73
14.56
2.7
2.3
—
—
—
0
0
1446
11944
1.29
14.12
5.6
4.5
0.0
0.0
estimate
0.88
435
3759
1015
8028
1.32
13.63
3.5
3.2
2.4
2.0
e6/l
0.76
582
4594
2201
19172
1.25
13.59
2.5
2.2
—
—
—
0
0
501
3555
1.45
13.03
5.6
6.6
25.7
24.5
mmol/l
12.39
466
3321
4044
37805
1.26
12.60
5.0
4.7
1.9
2.1
mu/l
3.66
3643
33527
1299
15438
0.79
11.65
2.8
3.2
7.5
7.2
mmol/l
1.14
1045
12637
2042
17851
1.23
11.64
2.2
2.2
77.1
79.5
nmol/l
3.23
1753
15483
1286
15274
0.79
11.42
2.9
3.3
291.9
320.9
mg/l
0.09
843
9829
68
272
2.52
11.35
1.0
1.0
280.4
286.8
mg/l
0.36
61
237
54
197
2.76
10.83
1.1
1.3
—
—
—
0
0
1886
16462
1.22
10.65
2.4
3.4
2.3
2.3
mmol/l
2.30
1592
13980
108
545
2.00
10.35
5.4
3.9
366.3
342.2
umol/l
0.93
100
453
1382
16142
0.81
10.29
3.6
4.0
6.9
9.8
mg/mmol
3.08
895
10265
336
2324
1.47
9.98
4.7
4.8
1.5
1.6
%
0.97
320
2179
82
379
2.18
9.92
1.3
1.3
—
—
—
0
0
926
11246
0.79
9.67
1.5
1.6
1.2
1.3
mmol/l
6.81
750
9249
1962
17326
1.21
9.56
2.7
2.9
145.3
163.2
ug/l
2.80
1741
15589
274
1854
1.50
9.10
2.0
2.2
1265.4
647.8
ug/l
0.30
253
1764
1145
9626
1.24
9.00
2.5
3.2
2.4
2.5
mmol/l
5.03
983
8361
788
6342
1.28
9.00
4.9
6.5
1.8
1.1
mmol/l
5.64
648
4879
3439
32058
1.19
8.90
3.9
4.3
12.6
14.6
mm/h
11.84
3145
29145
326
2296
1.45
8.84
4.8
4.8
0.9
0.9
%
0.29
311
2154
788
6362
1.28
8.77
4.9
6.5
5.2
5.1
kpa
3.60
746
6029
787
6361
1.28
8.67
4.9
6.5
11.8
11.9
kpa
0.11
742
6027
1098
9262
1.23
8.29
1.7
1.7
1.5
1.5
mg/l
0.29
882
7242
3780
39807
0.84
8.01
4.3
4.8
1.4
1.4
mmol/l
0.45
3358
35517
3647
38506
0.84
7.87
3.9
4.3
1.2
1.3
mmol/l
20.47
3204
33998
63
298
2.13
7.30
1.2
1.2
2.0
2.2
mmol/l
1.43
57
279
349
2576
1.38
7.29
4.6
4.0
47.6
47.3
%
0.10
342
2542
3833
40214
0.85
7.25
4.3
4.8
4.3
4.4
mmol/l
4.70
3432
36181
242
1685
1.46
7.03
3.3
4.1
3.8
3.9
mmol/l
2.28
228
1570
370
2788
1.35
6.79
3.6
3.4
25.6
25.1
mmol/l
1.73
349
2707
450
5733
0.77
6.72
2.7
4.0
11.1
24.3
ug/l
1.11
356
4799
639
5195
1.26
6.65
5.5
7.2
121.6
119.9
g/l
1.33
610
5007
2346
21492
1.16
6.61
10.4
11.4
1.3
1.4
inr
2.56
633
5823
129
794
1.64
6.57
2.7
2.4
106.1
105.6
mmol/l
0.49
129
784
129
794
1.64
6.57
2.7
2.4
4.1
4.1
mmol/l
0.04
129
784
4350
41809
1.19
6.45
20.4
17.9
27.5
27.5
mg/l
0.03
3735
34410
275
1997
1.40
6.37
3.1
3.9
1.2
1.4
mmol/l
6.13
268
1965
326
2454
1.35
6.05
2.3
2.4
33.2
25.3
au/ml
—
9
71
294
3916
0.74
6.03
1.3
1.3
—
—
—
0
0
63
322
1.97
6.00
1.1
1.1
—
31.9
—
0
6
427
3350
1.30
5.93
3.3
3.2
127.4
127.2
g/l
0.06
414
3268
3977
41409
0.86
5.91
4.9
5.5
2.5
2.5
mmol/l
4.60
3531
37062
43
191
2.26
5.88
1.1
1.1
—
—
—
0
0
331
2510
1.34
5.86
2.5
2.5
0.7
0.7
%
1.29
315
2406
294
2198
1.36
5.72
1.3
1.3
86.4
58.3
au/ml
0.82
13
97
1106
12597
0.85
5.59
2.4
2.9
8745.2
6016.0
umol/l
0.86
903
10604
46
215
2.15
5.58
1.2
1.1
272.7
317.9
mg/l
0.73
37
182
521
4224
1.26
5.56
3.1
3.0
4.5
4.5
kpa
0.04
502
4060
1145
10039
1.18
5.49
4.3
4.2
131.2
481.7
ng/l
3.60
979
8755
740
6249
1.21
5.39
8.8
8.4
—
—
—
0
0
470
3784
1.26
5.33
1.7
1.6
—
—
—
0
0
171
1180
1.46
5.30
1.5
1.3
—
—
—
0
0
171
1180
1.46
5.30
1.5
1.3
—
—
—
0
0
64
344
1.87
5.30
1.1
1.1
—
3.3
—
0
7
47
227
2.08
5.27
1.3
1.1
44.6
47.1
mg/l
0.10
36
189
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
42
199
2.12
4.96
1.1
1.1
—
—
—
0
0
20
66
3.04
4.94
2.3
2.2
—
—
—
0
0
20
66
3.04
4.94
2.3
2.2
—
—
—
0
0
1861
17027
1.14
4.92
2.9
3.2
1394.5
1849.6
ng/l
5.65
1601
14870
454
3688
1.25
4.79
1.8
2.2
391.1
376.7
nmol/l
0.80
397
3357
172
1221
1.42
4.63
6.0
6.4
105.3
105.1
mmol/l
0.29
156
1093
1616
14704
1.14
4.58
2.4
2.6
55.6
58.8
u/l
2.15
1487
13482
87
535
1.64
4.57
1.6
1.5
—
—
—
0
0
926
8113
1.17
4.41
2.2
3.0
0.8
0.8
mmol/l
3.33
838
7501
777
6712
1.18
4.40
4.8
6.5
104.6
104.3
mmol/l
0.91
755
6552
13
35
3.72
4.36
2.5
1.7
16.2
17.9
umol/l
0.31
13
35
75
452
1.67
4.28
2.6
2.0
1.9
1.7
u/field
0.06
21
155
111
1642
0.67
4.26
1.8
1.9
—
—
—
0
0
2256
21043
1.12
4.18
4.0
4.4
—
—
—
0
0
50
273
1.84
4.03
1.1
1.1
—
—
—
0
0
3628
34813
1.12
4.02
5.9
7.8
79.6
81.4
u/l
1.23
3367
32504
33
158
2.10
3.87
1.4
1.2
65.7
62.1
%
0.19
25
132
147
1054
1.41
3.81
1.7
2.5
25.8
34.5
umol/l
5.83
112
868
353
2870
1.25
3.75
3.1
2.9
0.3
0.3
e6/l
0.20
344
2818
557
4750
1.19
3.67
1.9
2.5
66.1
66.0
g/l
0.14
477
4238
142
1951
0.72
3.66
2.4
3.3
474.4
3225.3
u/ml
1.14
116
1663
763
6688
1.16
3.60
1.9
2.4
1.6
1.8
%
4.60
647
5847
598
5153
1.18
3.50
3.4
3.6
5.8
5.8
kpa
0.56
573
4981
497
5825
0.84
3.45
1.2
1.2
7.7
15.1
u/ml
2.28
182
1996
902
8044
1.15
3.36
2.0
2.0
30.0
30.1
s
0.28
873
7782
76
1149
0.66
3.33
2.2
2.7
1.6
1.8
mg/l
0.91
68
1012
593
5136
1.17
3.27
3.4
3.6
2.6
1.9
mmol/l
5.11
482
4129
214
1670
1.29
3.23
1.3
1.3
—
—
—
0
0
3799
39165
0.90
3.04
18.5
17.1
77.3
72.0
ml/min/173m2
54.63
3224
32522
37
203
1.83
3.02
1.1
1.0
—
—
—
0
0
22
100
2.20
2.99
1.0
1.1
—
—
—
0
0
154
1166
1.33
2.93
1.1
1.2
—
—
—
0
0
45
266
1.70
2.88
1.4
2.0
—
—
—
0
0
1272
11702
1.11
2.82
3.7
4.1
83.2
83.8
%
0.39
1240
11419
53
829
0.64
2.78
3.8
4.7
1008.8
3381.4
iu/ml
—
9
127
7
14
5.00
2.72
1.0
1.1
—
—
—
0
0
14
54
2.60
2.70
1.1
1.2
—
—
—
0
0
153
1175
1.31
2.66
1.2
1.2
—
—
—
0
0
23
112
2.06
2.66
1.0
1.1
—
—
—
0
0
118
1577
0.74
2.64
2.5
4.0
56.8
80.8
u/ml
0.33
113
1508
12
43
2.79
2.64
1.2
1.1
—
—
—
0
0
14
320
0.44
2.61
1.1
1.0
—
—
—
0
0
60
898
0.66
2.59
1.1
1.3
35.0
41.5
u/l
0.19
50
776
527
5998
0.87
2.56
4.4
4.9
34.9
33.3
%
2.50
333
3854
397
3403
1.18
2.53
5.6
8.2
0.7
0.7
%
3.54
392
3374
46
724
0.63
2.52
1.1
1.1
—
—
—
0
0
20
393
0.51
2.47
1.5
1.5
—
—
—
0
0
70
479
1.47
2.46
1.3
1.3
112152.9
155731.6
e6/l
0.21
56
331
22
109
2.02
2.45
1.1
1.1
—
—
—
0
0
250
2060
1.22
2.45
2.4
3.2
4.4
4.3
pmol/l
0.71
208
1776
397
3419
1.17
2.41
5.4
8.0
1.4
1.3
%
0.52
391
3394
824
7478
1.12
2.33
1.2
1.2
1.5
1.8
u/ml
0.32
197
1813
46
291
1.59
2.32
1.5
1.7
—
—
—
0
0
284
2385
1.20
2.31
1.9
1.9
2.1
2.7
ug/l
0.36
233
2065
3858
39566
0.92
2.29
6.4
6.7
40.5
41.1
mmol/mol
3.85
3478
35750
95
697
1.37
2.29
1.8
2.1
27.3
25.9
mg/l
0.07
24
162
78
1082
0.72
2.26
1.3
1.2
—
—
—
0
0
40
632
0.63
2.26
1.6
2.3
—
2255.2
—
0
47
595
5307
1.14
2.24
4.6
3.8
—
—
—
0
0
575
5119
1.14
2.23
2.4
2.5
6.3
6.8
ug/l
0.36
426
4392
92
1239
0.74
2.22
1.5
1.5
—
—
—
0
0
179
1443
1.25
2.18
1.2
1.2
—
—
—
0
0
65
922
0.70
2.17
2.2
3.7
2.9
1.5
%
0.64
44
681
38
600
0.63
2.16
1.1
1.2
—
—
—
0
0
2135
20337
1.08
2.13
5.0
5.9
2.7
2.9
%
3.79
1950
18730
894
8192
1.11
2.12
2.1
2.6
11.4
12.1
umol/l
2.36
793
7508
64
906
0.70
2.12
1.3
1.6
—
—
—
0
0
11
43
2.56
2.09
1.2
1.2
—
—
—
0
0
28
160
1.75
2.09
1.1
1.0
1.0
1.2
u/l
2.96
13
83
211
1741
1.22
2.09
2.0
2.2
38.2
37.2
g/l
1.85
172
1457
4505
44236
1.10
2.06
24.0
21.4
139.7
139.6
mmol/l
2.88
4407
43004
2140
20410
1.08
2.05
5.1
5.8
60.5
58.7
%
9.78
1954
18820
133
1045
1.28
2.03
1.6
1.7
—
—
—
0
0
36
565
0.63
2.01
2.3
3.6
62.2
58.6
%
0.32
23
336
37
231
1.61
2.01
1.3
1.5
6.0
6.7
u/l
0.19
30
193
16
313
0.51
2.00
1.2
1.2
—
—
—
0
0
21
111
1.90
2.00
1.1
1.1
—
—
—
0
0
13
57
2.28
1.97
1.2
1.2
—
—
—
0
0
2172
20756
1.08
1.95
5.3
6.0
24.7
25.9
%
4.92
1965
19029
63
879
0.71
1.94
1.4
1.7
1.8
3.5
mg/l
1.56
46
648
12
256
0.47
1.94
1.2
1.8
—
—
—
0
0
12
256
0.47
1.94
1.2
1.8
—
—
—
0
0
12
256
0.47
1.94
1.2
1.8
—
—
—
0
0
12
256
0.47
1.94
1.2
1.8
—
—
—
0
0
67
925
0.72
1.94
1.2
1.2
2.9
5.7
u/ml
1.31
13
145
4508
44305
1.10
1.91
24.1
21.5
4.0
4.0
mmol/l
14.29
4405
43013
20
106
1.89
1.90
1.1
1.1
—
—
—
0
0
476
4235
1.14
1.90
3.0
4.0
1.2
1.2
mmol/l
0.28
407
3686
7
22
3.18
1.88
1.1
1.0
—
—
—
0
0
298
3449
0.86
1.87
1.3
1.3
—
—
—
0
0
27
160
1.69
1.81
3.4
5.6
70.8
71.6
%
0.04
19
125
14
275
0.51
1.80
1.5
1.1
—
—
—
0
0
19
101
1.88
1.80
1.0
1.1
—
—
—
0
0
67
911
0.73
1.79
1.2
1.2
3.3
3.4
u/ml
0.03
11
87
7
166
0.42
1.78
1.0
2.0
—
21193.4
—
0
24
445
4986
0.88
1.77
4.6
6.7
10.4
11.2
mmol/l
1.61
403
4703
154
1256
1.23
1.75
2.0
2.2
127.1
126.9
g/l
0.04
125
909
27
435
0.62
1.73
1.1
1.6
—
—
—
0
0
27
435
0.62
1.73
1.1
1.6
—
—
—
0
0
27
435
0.62
1.73
1.1
1.6
—
—
—
0
0
8
30
2.67
1.72
1.3
1.1
—
—
—
0
0
565
6230
0.90
1.71
1.2
1.3
42.1
39.9
iu/ml
0.08
153
1885
2542
24511
1.07
1.71
4.3
6.3
11.9
12.4
umol/l
1.40
2383
23192
516
4656
1.12
1.66
4.6
6.3
1.3
1.4
mmol/l
0.87
496
4453
13
62
2.10
1.65
2.5
1.4
—
—
—
0
0
2607
25181
1.07
1.64
6.8
8.7
4.4
4.3
e9/l
0.09
2223
21740
248
2131
1.17
1.64
2.0
1.8
—
—
—
0
0
74
975
0.76
1.62
1.2
1.2
53.9
42.4
u/ml
—
6
52
145
1189
1.23
1.60
1.7
1.6
13079.3
15656.6
e6/l
0.34
110
849
132
1616
0.81
1.59
1.6
1.6
76.0
234.2
titre
—
5
73
37
544
0.68
1.58
1.1
1.2
320.0
304.5
u/ml
0.10
21
323
4019
40936
0.93
1.53
4.9
5.2
6.0
6.1
mmol/l
4.21
3546
36265
194
1644
1.19
1.53
2.1
2.3
0.0
0.1
g/l
0.09
173
1482
27
169
1.60
1.51
1.5
1.5
1.6
23.8
u/l
—
10
52
84
651
1.29
1.50
3.9
18.9
7.2
7.5
mmol/l
0.50
70
533
21
123
1.71
1.50
1.3
1.5
13.7
17.3
pmol/l
1.93
14
97
179
1510
1.19
1.49
2.1
2.3
0.0
0.0
g/l
0.00
159
1375
33
488
0.67
1.47
1.2
1.2
2.6
3.4
u/ml
0.23
11
144
21
124
1.70
1.46
1.7
1.5
0.3
0.4
ug/l
1.21
14
66
220
1894
1.17
1.45
2.0
2.4
0.4
1.1
g/l
5.32
181
1590
133
1094
1.22
1.45
4.2
3.7
28.1
30.7
mg/l
0.33
83
718
22
133
1.66
1.42
1.2
1.1
—
—
—
0
0
243
2114
1.16
1.41
1.9
2.3
9.8
10.3
g/l
1.35
199
1751
181
1538
1.18
1.41
2.1
2.3
0.0
0.0
g/l
0.50
160
1381
819
7634
1.09
1.38
2.1
2.6
2.2
2.3
g/l
0.20
724
6995
35
503
0.69
1.36
1.0
1.1
—
—
—
0
0
270
3062
0.88
1.35
2.8
2.7
10.1
10.6
g/l
1.00
239
2761
28
183
1.53
1.34
1.0
1.1
—
—
—
0
0
60
787
0.76
1.33
1.2
1.2
3.0
6.0
u/ml
—
6
56
560
5144
1.10
1.32
3.1
3.1
221.5
250.0
ng/l
0.92
507
4743
42
581
0.72
1.32
1.1
1.4
116.3
124.6
u/ml
—
10
122
18
106
1.70
1.29
1.1
1.1
—
—
—
0
0
37
520
0.71
1.29
1.0
1.1
1.5
1.6
g/l
1.22
30
463
256
2253
1.14
1.28
1.9
2.3
3.7
3.8
g/l
0.62
178
1579
37
259
1.43
1.28
2.1
1.8
1.1
2.4
u/field
1.76
21
177
256
2256
1.14
1.26
1.9
2.3
—
—
—
0
0
93
1146
0.81
1.25
2.3
3.2
293.9
812.9
u/ml
1.01
84
1050
25
162
1.55
1.25
2.3
2.0
53.3
55.6
umol/l
0.09
16
128
256
2259
1.14
1.24
1.9
2.3
7.2
7.5
g/l
1.90
178
1640
261
2307
1.14
1.24
2.0
1.9
—
—
—
0
0
3368
32952
1.06
1.24
23.6
21.8
13.8
13.9
%
9.98
3288
32113
64
822
0.78
1.23
1.5
1.5
1844.0
2020.1
e6/l
0.13
42
596
367
3315
1.11
1.22
3.2
3.7
2.3
1.9
mmol/l
1.53
270
2414
45
606
0.74
1.22
1.8
1.5
58.9
62.9
%
0.30
31
382
58
753
0.77
1.21
1.5
1.5
87768.1
66492.6
e6/l
0.27
28
443
8
37
2.16
1.21
1.0
1.2
—
—
—
0
0
385
3489
1.11
1.21
3.3
3.8
5.2
5.1
kpa
0.62
347
3184
52
391
1.33
1.20
1.3
1.4
—
—
—
0
0
24
156
1.54
1.19
2.7
2.7
25.3
29.7
umol/l
0.99
15
116
100
1215
0.82
1.19
1.3
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
181
2087
0.86
1.18
2.4
2.8
0.4
0.3
u/ml
1.02
110
1205
16
94
1.70
1.17
1.1
1.1
—
—
—
0
0
103
849
1.22
1.16
1.9
1.7
—
—
—
0
0
23
345
0.67
1.15
1.1
1.1
—
90.2
—
0
12
11
198
0.55
1.15
1.4
2.0
—
—
—
0
0
592
6374
0.92
1.15
2.6
4.0
234.0
246.0
u/l
1.67
542
5967
34
473
0.72
1.14
1.2
1.2
2.4
5.0
u/ml
2.04
14
213
1723
16582
1.06
1.14
4.6
4.8
22.4
22.1
%
0.37
897
8933
96
1165
0.82
1.14
1.3
1.6
—
—
—
0
0
11
197
0.56
1.13
1.2
2.0
—
—
—
0
0
11
197
0.56
1.13
1.2
2.0
—
—
—
0
0
67
843
0.79
1.11
1.3
1.2
—
—
—
0
0
7
137
0.51
1.09
1.0
1.2
—
—
—
0
0
52
398
1.31
1.09
1.3
1.4
—
—
—
0
0
235
2085
1.13
1.08
1.9
2.4
3.1
3.1
g/l
0.07
179
1611
10
52
1.92
1.06
1.0
1.1
—
—
—
0
0
69
553
1.25
1.03
2.6
3.2
—
—
—
0
0
2134
20712
1.05
1.00
4.9
5.6
5.0
4.1
ug/l
0.31
1882
18292
0
29
0.00
0.97
0.0
1.1
—
1.9
—
0
15
9
50
1.80
0.96
3.8
2.6
0.7
0.4
u/field
—
9
50
10
174
0.57
0.96
1.2
1.4
35.4
22.6
%
—
10
141
129
1495
0.86
0.95
1.7
1.7
—
—
—
0
0
27
191
1.42
0.94
1.1
1.1
—
—
—
0
0
17
109
1.56
0.93
1.2
1.1
1394.5
1644.8
miu/ml
0.34
17
109
32
234
1.37
0.93
1.4
1.7
—
—
—
0
0
1126
11762
0.95
0.93
3.1
3.3
0.8
0.8
ug/l
1.70
809
8555
431
3992
1.09
0.91
1.9
2.0
215.6
168.7
ug/g
1.12
345
3060
45
576
0.78
0.91
3.9
3.5
—
—
—
0
0
5
105
0.48
0.88
1.2
1.1
—
—
—
0
0
178
2004
0.88
0.88
2.7
2.6
—
—
—
0
0
49
386
1.27
0.87
1.4
1.3
35.1
33.2
iu/l
0.12
42
324
98
1148
0.85
0.85
1.4
1.6
0.5
12.1
iu/ml
1.19
33
279
22
310
0.71
0.85
2.7
3.6
—
—
—
0
0
90
1061
0.85
0.84
2.7
2.3
185.3
208.1
%
1.88
84
1010
231
2086
1.11
0.84
3.7
4.2
25.4
24.8
mmol/l
2.81
202
1895
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
59
723
0.81
0.83
1.3
1.5
—
—
—
0
0
760
7215
1.06
0.83
2.2
2.6
21.2
21.7
%
0.43
600
6050
8
140
0.57
0.82
1.9
1.8
—
—
—
0
0
35
455
0.77
0.81
1.3
1.3
—
—
—
0
0
145
1277
1.14
0.81
2.5
2.8
8.0
7.8
kpa
0.71
140
1168
11
177
0.62
0.81
1.2
1.3
—
—
—
0
0
14
89
1.57
0.81
1.2
1.3
66.7
79.3
%
—
6
52
53
654
0.81
0.81
1.3
1.3
318.0
325.8
u/l
0.04
48
616
55
445
1.24
0.80
1.6
1.7
35.3
26.8
u/ml
0.62
17
100
36
465
0.77
0.80
1.1
1.7
—
—
—
0
0
98
1140
0.86
0.79
2.1
2.1
91.9
87.9
%
1.08
93
1086
90
766
1.18
0.79
1.1
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
3.8
—
—
—
0
0
85
721
1.18
0.78
5.5
6.1
12.4
12.2
mg/l
0.10
74
663
833
7951
1.06
0.76
25.9
30.3
1.4
1.5
inr
0.33
81
1105
125
1421
0.88
0.75
3.2
3.1
0.8
0.8
nmol/l
1.37
94
1069
1933
18828
1.04
0.75
10.7
10.5
0.0
0.0
e9/l
0.05
1551
15271
153
1715
0.89
0.74
1.4
1.7
37.2
38.0
u/l
0.21
129
1453
33
425
0.78
0.73
1.0
1.1
—
—
—
0
0
31
402
0.77
0.73
1.5
1.2
8.1
7.8
mmol/l
0.23
21
284
20
277
0.72
0.72
2.9
1.9
16.9
14.8
%
0.28
11
108
47
579
0.81
0.72
3.9
3.4
3.5
17.6
nmol/l
0.85
42
566
13
195
0.67
0.72
1.1
1.2
—
—
—
0
0
175
1942
0.90
0.72
1.3
1.3
477.1
236.1
u/ml
0.54
156
1753
53
640
0.83
0.68
1.1
1.2
—
42.0
—
0
70
14
204
0.69
0.68
1.1
1.0
—
—
—
0
0
7
121
0.58
0.67
1.1
1.1
—
—
—
0
0
27
205
1.32
0.67
1.0
1.1
—
—
—
0
0
5
94
0.53
0.66
1.0
1.4
—
—
—
0
0
13
86
1.51
0.66
1.2
1.1
76.3
81.7
%
—
6
48
99
1129
0.87
0.65
1.6
1.6
—
—
—
0
0
15
213
0.70
0.64
1.2
1.3
14.9
539.6
ug/l
—
8
103
35
438
0.80
0.64
1.1
1.1
—
—
—
0
0
155
1397
1.11
0.64
1.4
1.5
274.2
261.2
ug/g
0.35
96
857
154
1388
1.11
0.63
1.4
1.6
—
—
—
0
0
489
5164
0.94
0.63
2.3
2.7
8.3
9.7
umol/l
0.85
428
4494
10
153
0.65
0.62
2.9
2.0
14.5
54.2
u/l
—
10
140
17
121
1.41
0.62
1.6
1.2
—
—
—
0
0
92
805
1.15
0.61
1.3
1.7
3.5
4.3
iu/l
0.39
23
232
61
518
1.18
0.60
2.0
1.7
236.0
301.8
mu/l
1.78
54
478
119
1062
1.12
0.59
1.4
1.4
—
—
—
0
0
20
148
1.35
0.59
1.1
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
440
4168
1.06
0.56
2.3
2.4
40.6
38.8
u/l
0.08
365
3538
6
37
1.62
0.55
1.2
1.1
—
—
—
0
0
1350
13138
1.04
0.55
2.7
3.2
30.5
37.6
u/l
2.92
1253
12326
19
251
0.76
0.55
1.2
1.1
—
—
—
0
0
19
251
0.76
0.55
1.2
1.1
—
—
—
0
0
19
251
0.76
0.55
1.2
1.1
—
—
—
0
0
25
317
0.79
0.54
1.5
1.5
—
—
—
0
0
2506
24648
1.03
0.53
3.1
3.2
49.3
57.7
u/l
2.47
2265
22206
21
160
1.31
0.53
1.1
1.2
—
—
—
0
0
11
74
1.49
0.53
1.3
1.2
—
—
—
0
0
25
316
0.79
0.52
1.5
1.5
—
—
—
0
0
50
588
0.85
0.52
1.4
1.5
—
—
—
0
0
24
304
0.79
0.51
1.1
1.1
0.2
1.7
u/ml
—
5
117
9
133
0.68
0.51
1.9
2.6
—
—
—
0
0
12
83
1.45
0.51
1.7
1.3
3.6
2.3
umol/l
1.52
12
77
19
248
0.77
0.51
1.2
1.1
—
—
—
0
0
19
248
0.77
0.51
1.2
1.1
—
—
—
0
0
13
180
0.72
0.51
4.5
4.4
—
64.9
—
0
30
41
489
0.84
0.51
1.1
1.6
—
—
—
0
0
39
467
0.83
0.50
1.6
1.4
12.7
13.1
u/l
0.22
39
442
53
453
1.17
0.50
1.7
1.4
24.6
25.7
%
0.09
39
279
13
92
1.41
0.50
1.3
1.6
77.1
157.1
ng/l
2.92
13
92
78
883
0.88
0.50
2.5
3.6
57.7
58.9
%
0.37
78
883
6
41
1.46
0.50
1.0
1.1
—
—
—
0
0
96
1070
0.90
0.48
1.4
1.8
10.3
12.8
mg/l
2.26
89
970
1173
11416
1.03
0.48
2.3
2.5
—
—
—
0
0
7
47
1.49
0.47
1.0
1.0
—
—
—
0
0
415
3954
1.05
0.46
2.8
3.8
83.0
98.9
ng/l
3.18
332
3332
4539
45111
1.04
0.44
29.0
26.5
130.6
133.0
g/l
23.02
4463
44181
4538
45102
1.04
0.44
28.8
26.3
4.3
4.4
e12/l
16.78
4389
43440
11
152
0.72
0.44
1.1
1.2
5.2
13.9
umol/l
—
6
94
294
2780
1.06
0.44
1.5
1.7
1.5
1.6
g/l
0.16
242
2382
4537
45096
1.03
0.43
28.8
26.3
237.3
238.7
e9/l
0.78
4411
43615
85
764
1.11
0.42
1.4
1.4
—
—
—
0
0
3600
35671
1.03
0.42
21.9
19.4
37.4
38.4
%
5.30
2053
21539
23
283
0.81
0.41
1.4
1.8
—
—
—
0
0
65
576
1.13
0.41
1.4
1.3
0.8
0.2
nmol/l
3.71
29
39
41
477
0.86
0.41
1.3
1.2
54.5
62.4
u/l
0.60
24
316
0
17
0.00
0.40
0.0
1.2
—
3.1
—
0
17
16
123
1.30
0.40
1.1
1.1
—
—
—
0
0
22
271
0.81
0.40
3.0
1.8
—
—
—
0
0
4537
45115
1.03
0.39
28.9
26.3
6.8
6.9
e9/l
1.27
4392
43442
62
696
0.89
0.38
1.2
1.4
—
—
—
0
0
123
1331
0.92
0.37
2.2
2.3
112.6
97.4
ug/min
0.22
74
761
146
1360
1.08
0.36
1.4
1.4
—
—
—
0
0
110
1014
1.09
0.35
1.9
1.6
—
—
—
0
0
20
163
1.23
0.34
1.8
2.3
—
—
—
0
0
20
163
1.23
0.34
1.8
2.3
—
—
—
0
0
6
45
1.33
0.33
1.0
1.0
—
—
—
0
0
13
100
1.30
0.33
1.2
1.3
0.3
0.3
g/l
—
8
75
6
90
0.67
0.32
1.0
1.2
—
—
—
0
0
19
231
0.82
0.32
1.8
1.4
1.0
1.4
u/ml
0.17
13
125
6
47
1.28
0.32
1.8
1.5
—
—
—
0
0
7
96
0.73
0.30
1.0
1.1
—
4.6
—
0
15
32
277
1.16
0.30
1.2
1.3
0.6
1.1
promille
1.84
27
211
39
442
0.88
0.30
2.2
2.2
492.6
659.2
ml
3.26
27
263
26
222
1.17
0.29
1.3
1.2
—
—
—
0
0
33
288
1.15
0.29
1.3
1.4
—
—
—
0
0
33
288
1.15
0.29
1.3
1.4
—
—
—
0
0
127
1192
1.07
0.28
2.9
2.5
16.2
15.8
%
0.69
85
628
14
173
0.81
0.28
2.3
4.8
13.3
13.4
%
0.11
14
173
10
129
0.77
0.28
2.5
2.3
6.5
7.8
mmol/l
—
5
82
8
62
1.29
0.28
1.0
1.1
—
—
—
0
0
8
62
1.29
0.28
1.0
1.0
—
—
—
0
0
24
280
0.86
0.28
1.5
1.2
93.2
93.4
u/l
0.00
19
240
25
214
1.17
0.27
1.6
1.6
0.9
0.9
g/l
1.03
25
214
157
1487
1.06
0.27
2.5
3.1
25.4
24.9
mmol/l
0.70
144
1279
81
750
1.08
0.26
1.4
1.2
—
—
—
0
0
30
342
0.88
0.26
1.1
1.0
4.7
2.2
u/ml
—
5
85
63
687
0.92
0.26
1.1
1.2
—
—
—
0
0
44
395
1.11
0.26
1.1
1.1
—
—
—
0
0
8
67
1.19
0.26
1.0
1.1
—
—
—
0
0
445
4581
0.97
0.25
2.0
2.1
0.2
0.2
g/l
0.10
404
4224
42
378
1.11
0.24
1.3
1.4
1096.4
167.1
titre
0.83
11
38
6
85
0.71
0.24
1.0
1.3
—
—
—
0
0
186
1944
0.96
0.23
1.9
3.3
29.8
57.4
mg/l
3.09
151
1594
4373
43902
0.98
0.23
9.9
11.5
19.0
25.3
u/l
103.49
4088
41899
25
285
0.88
0.23
1.8
1.6
1.9
7.2
u/l
—
9
133
20
232
0.86
0.22
1.1
1.1
77.8
88.0
u/l
0.26
14
177
20
232
0.86
0.22
1.1
1.1
21.1
33.8
u/l
0.86
15
174
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
1.2
—
0
5
0
10
0.00
0.21
0.0
1.3
—
0.4
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
2.3
—
0
5
0
11
0.00
0.21
0.0
5.0
—
363.3
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
6
0
12
0.00
0.21
0.0
1.0
—
1.0
—
0
12
0
12
0.00
0.21
0.0
6.7
—
45.6
—
0
12
187
1947
0.96
0.21
1.9
3.3
45.2
92.1
mg/l
0.96
153
1595
23
262
0.88
0.21
1.1
1.2
10.2
12.2
mmol/l
—
6
83
15
126
1.19
0.21
1.2
1.4
—
—
—
0
0
113
1191
0.95
0.21
2.2
2.2
3.6
3.6
g/l
0.03
104
1129
0
14
0.00
0.20
0.0
1.1
—
7.8
—
0
14
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
126
1200
1.05
0.20
4.0
4.8
2.4
2.7
mmol/l
0.72
100
817
12
99
1.21
0.19
2.2
2.2
164.2
217.3
%
1.14
12
91
84
891
0.94
0.19
1.4
1.4
—
—
—
0
0
42
458
0.92
0.19
1.4
1.6
—
—
—
0
0
179
1860
0.96
0.19
1.2
1.2
73.3
129.1
iu/ml
1.95
69
618
24
269
0.89
0.18
1.5
1.2
20.7
24.5
u/l
0.21
19
226
57
532
1.07
0.17
1.1
1.3
244.3
264.6
pmol/l
0.24
39
396
66
702
0.94
0.17
1.3
1.4
—
—
—
0
0
5
70
0.71
0.16
15.8
13.2
5.4
5.3
mmol/l
—
5
70
31
282
1.10
0.16
1.3
1.4
—
—
—
0
0
31
282
1.10
0.16
1.3
1.4
—
—
—
0
0
37
340
1.09
0.16
1.1
1.2
—
—
—
0
0
60
638
0.94
0.16
1.2
1.3
—
—
—
0
0
106
1107
0.96
0.15
1.5
1.4
0.2
0.2
g/l
0.27
100
1046
53
564
0.94
0.15
1.3
1.4
—
—
—
0
0
24
265
0.91
0.15
2.2
3.5
—
—
—
0
0
316
3230
0.98
0.14
1.8
2.1
12.3
11.9
nmol/l
0.41
270
2751
363
3701
0.98
0.13
3.1
2.8
66.0
60.1
ml/min/173m2
1.85
136
1606
10
117
0.85
0.13
1.0
1.4
1.7
1.9
umol/l
—
10
108
54
569
0.95
0.12
1.0
1.1
42.0
351.8
iu/ml
0.52
11
107
5
45
1.11
0.09
1.4
1.7
—
—
—
0
0
68
707
0.96
0.09
2.4
1.9
89.2
89.0
%
0.17
68
699
75
778
0.96
0.09
1.2
1.4
—
—
—
0
0
670
6768
0.99
0.09
3.7
5.6
1.0
1.0
mmol/l
3.91
604
6221
10
87
1.15
0.09
1.1
1.1
—
—
—
0
0
186
1898
0.98
0.09
1.8
3.2
1.4
3.5
ratio
—
8
138
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
19
206
0.92
0.08
1.3
1.4
98.5
185.9
pmol/l
—
9
73
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
6
58
1.03
0.08
1.7
1.7
—
—
—
0
0
66
638
1.03
0.07
1.3
1.4
—
—
—
0
0
6
73
0.82
0.07
1.0
1.3
—
—
—
0
0
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
284
2876
0.99
0.07
5.9
8.3
24.7
24.3
mmol/l
1.51
264
2638
65
630
1.03
0.06
1.3
1.4
—
—
—
0
0
101
987
1.02
0.06
1.4
1.5
—
—
—
0
0
247
2502
0.99
0.06
3.0
3.8
25.1
24.1
mmol/l
4.65
209
2231
64
623
1.03
0.05
1.3
1.4
—
—
—
0
0
44
426
1.03
0.05
1.4
1.4
—
—
—
0
0
158
1559
1.01
0.04
1.0
1.1
—
—
—
0
0
14
150
0.93
0.04
1.1
1.4
39.8
106.9
umol/l
—
5
88
112
1137
0.98
0.04
1.5
1.4
1.1
1.2
g/l
0.46
106
1073
139
1372
1.01
0.04
1.1
1.2
1.5
1.1
u/ml
0.11
17
135
11
119
0.92
0.04
1.0
1.0
—
—
—
0
0
12
129
0.93
0.03
1.0
1.3
40.9
32.1
%
—
7
83
16
151
1.06
0.03
1.1
1.2
1.1
1.1
ratio
—
5
44
23
221
1.04
0.03
1.2
1.2
—
—
—
0
0
64
629
1.02
0.02
1.3
1.4
—
—
—
0
0
64
629
1.02
0.02
1.3
1.4
—
—
—
0
0
17
162
1.05
0.02
1.0
1.3
33.6
21.5
umol/l
0.68
17
153
37
361
1.03
0.02
1.4
1.5
—
—
—
0
0
64
631
1.01
0.01
1.3
1.4
—
—
—
0
0
23
223
1.03
0.01
1.2
1.2
—
—
—
0
0
85
858
0.99
0.01
1.2
1.4
—
—
—
0
0
31
317
0.98
0.01
1.2
1.2
68.8
126.9
titre
—
8
55
11
104
1.06
0.01
1.2
1.9
—
—
—
0
0
15
144
1.04
0.00
1.1
1.2
—
—
—
0
0
18
174
1.03
0.00
2.2
1.7
3.0
8.3
nmol/l
1.23
18
151
11
111
0.99
0.00
1.0
1.1
—
—
—
0
0
15
146
1.03
0.00
1.3
1.3
—
—
—
0
0
84
841
1.00
0.00
1.3
1.4
0.7
0.8
nmol/l
1.35
68
687
29
292
0.99
0.00
4.7
4.9
77.6
48.5
u/ml
—
9
82
18
175
1.03
0.00
1.1
1.1
—
—
—
0
0
11
115
0.96
0.00
1.3
1.4
—
—
—
0
0
329
3291
1.00
0.00
1.6
1.7
1.5
1.6
%
3.01
278
2714
60
600
1.00
0.00
1.2
1.3
10.4
10.3
u/l
0.04
46
484
31
308
1.01
0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
4.1
—
—
—
0
0
0
8
0.00
0.00
0.0
7.0
—
—
—
0
0
5
59
0.85
0.00
1.2
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
0.00
1.6
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
78
0.90
0.00
1.1
1.2
—
—
—
0
0
6
66
0.91
0.00
3.3
3.3
34.9
41.1
umol/l
—
6
55
0
5
0.00
0.00
0.0
5.8
—
14.0
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDSTRICT – Parkinson's disease, strict definition
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).